The SADHART (Sertraline Antidepressant Heart Attack Randomized Trial) study was a placebo-controlled trial of the SSRI sertraline in 369 patients with acute coronary syndrome who met diagnostic criteria for major depression (Glassman et al. Arch Gen Psychiatry 2009; 66: 102-1029).